Fundamental Valuation Report Abbott Laboratories(ABT:NYS) Healthcare:Medical Devices This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$76.86 (USD) 25/02/2019 Weighted Valuation$75.98 (USD) Overall RatingFairly valued to slightly Overvalued by 1.1% Valuation Models …
Abbott Laboratories (ABT:NYS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Autoliv(ALV:NYS) Consumer Cyclical:Auto Parts This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$81.23 (USD) 22/02/2019 Weighted Valuation$88.00 (USD) Overall RatingUndervalued by 8.3% Valuation Models Analyst Consensus: $93.00 (USD) …
Autoliv (ALV:NYS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Arconic(ARNC:NYS) Industrials:Diversified Industrials This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$18.28 (USD) 22/02/2019 Weighted Valuation$24.16 (USD) Overall RatingUndervalued by 32.2% Valuation Models Analyst Consensus: $24.67 (USD) (in …
Arconic (ARNC:NYS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Altus Group(AIF:TSE) Real Estate:Real Estate Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$23.85 (CAD) 22/02/2019 Weighted Valuation$29.30 (CAD) Overall RatingUndervalued by 22.8% Valuation Models Analyst …
Altus Group (AIF:TSE) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report AptarGroup(ATR:NYS) Consumer Cyclical:Packaging & Containers This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$102.05 (USD) 22/02/2019 Weighted Valuation$99.56 (USD) Overall RatingFairly valued to slightly Overvalued by 2.4% Valuation …
AptarGroup (ATR:NYS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report bluebird bio(BLUE:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$131.32 (USD) 22/02/2019 Weighted Valuation$154.06 (USD) Overall RatingUndervalued by 17.3% Valuation Models Analyst Consensus: $150.00 (USD) (in …
bluebird bio (BLUE:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Avis Budget Group(CAR:NAS) Industrials:Rental & Leasing Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$35.33 (USD) 22/02/2019 Weighted Valuation$41.00 (USD) Overall RatingUndervalued by 16.0% Valuation Models …
Avis Budget Group (CAR:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Commerce Bancshares(CBSH:NAS) Financial Services:Banks-Regional-US This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$63.51 (USD) 22/02/2019 Weighted Valuation$61.06 (USD) Overall RatingFairly valued to slightly Overvalued by 3.9% Valuation Models …
Commerce Bancshares (CBSH:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Citizens Financial Group(CFG:NYS) Financial Services:Banks-Regional-US This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$37.23 (USD) 22/02/2019 Weighted Valuation$40.01 (USD) Overall RatingUndervalued by 7.5% Valuation Models Analyst Consensus: $45.75 …
Citizens Financial Group (CFG:NYS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report Avista(AVA:NYS) Utilities:Utilities-Diversified This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$41.37 (USD) 21/02/2019 Weighted Valuation$41.61 (USD) Overall RatingFairly valued to slightly Undervalued by 0.6% Valuation Models Analyst Consensus: $40.00 …
Avista (AVA:NYS) Fundamental Valuation Report Read more »
Read More